APA

Swanner J., Fahrenholtz C. D., Tenvooren I., Bernish B. W., Sears J. J., Hooker A., Furdui C. M., Alli E., Li W., Donati G. L., Cook K. L., Vidi P. & Singh R. (2019). Silver nanoparticles selectively treat triple-negative breast cancer cells without affecting non-malignant breast epithelial cells in vitro and in vivo. : FASEB bioAdvances.

Chicago

Swanner Jessica, Fahrenholtz Cale D, Tenvooren Iliana, Bernish Brian W, Sears James J, Hooker Allison, Furdui Cristina M, Alli Elizabeth, Li Wencheng, Donati George L, Cook Katherine L, Vidi Pierre-Alexandre and Singh Ravi. 2019. Silver nanoparticles selectively treat triple-negative breast cancer cells without affecting non-malignant breast epithelial cells in vitro and in vivo. : FASEB bioAdvances.

Harvard

Swanner J., Fahrenholtz C. D., Tenvooren I., Bernish B. W., Sears J. J., Hooker A., Furdui C. M., Alli E., Li W., Donati G. L., Cook K. L., Vidi P. and Singh R. (2019). Silver nanoparticles selectively treat triple-negative breast cancer cells without affecting non-malignant breast epithelial cells in vitro and in vivo. : FASEB bioAdvances.

MLA

Swanner Jessica, Fahrenholtz Cale D, Tenvooren Iliana, Bernish Brian W, Sears James J, Hooker Allison, Furdui Cristina M, Alli Elizabeth, Li Wencheng, Donati George L, Cook Katherine L, Vidi Pierre-Alexandre and Singh Ravi. Silver nanoparticles selectively treat triple-negative breast cancer cells without affecting non-malignant breast epithelial cells in vitro and in vivo. : FASEB bioAdvances. 2019.